Appian: Not Cheap, But Ongoing Improvements Probably Warrant More Positive Investor Interest

Appian buy case: agentic AI launch, better cost control and rising FCF support 30% EBITDA growth despite a premium valuation.

Is Clorox (CLX) Pricing Look Attractive After Recent Share Price Rebound

If you are wondering whether Clorox is attractively priced or still has risk baked into its share price, this article walks through what the current numbers actually say about value. The stock last ...

Corning's Meta deal and earnings tell us this stock is nowhere near done going up

The stock, not surprisingly, dropped more than 4% after Tuesday's monster rally on the Meta Platforms data center order. Core ...

Is AI superstar Palantir Technologies going to plunge in 2026? History offers 2 undeniable clues.

When things seem too good to be true for Wall Street's hottest artificial intelligence (AI) stock, they often are.

Hyatt Hotels: Plenty Of Room At The Top As We Approach Q4 Earnings Release

Pivoting to this model enables stronger free cash flow generation due to reduced investment levels per location, all things ...

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

Genus' estimated fair value is UK£31.90 based on 2 Stage Free Cash Flow to Equity. With UK£29.70 share price, Genus appears to be trading close to its estimated fa ...